Japans Prime Minister Shinzo Abe has had his country printing more money than the Federal Reserve. In fact, the amount they have printed has made the Federal Reserve look like they barely print at all. Japan did this all to try and stimulate their economy through consumer spending. How? Let me explain. The idea of global Federal Reserve banks has been to create inflation. By creating inflation you increase prices. If the consumer knows that prices will be higher in the future, they will buy today. That is the theory at least...

Read more: Japanese Shocking Recession Should Freak You Out

Mining Stocks News: SilverCrest (TSX: SVL) (NYSE MKT: SVLC) Options Cumobabi Property

Vancouver, BC - November 18, 2014 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX:SVL) (NYSE MKT: SVLC) is pleased to announce it has signed a five year option agreement (the “Agreement”) with Evrim Resources Corp. (TSX.V: EVM) (“Evrim”) whereby SilverCrest can acquire a 100% interest in Evrim’s Cumobabi Property in the State of Sonora, Mexico. The Cumobabi Property is in the general vicinity of the Santa Elena mine and adjacent to the Ermitaño Property which was previously optioned by the Company (see news release dated January 14, 2014).

Read more: SilverCrest Mines Inc ( SVL / SVLC )

Medical Technology Breaking News: Aethlon Medical's (OTCBB: AEMD) Hemopurifier® Used in Successful Treatment of Patient with Advanced Ebola Infection

242 Million Copies of Ebola Virus Removed from Patient during Treatment, Physician Reports at American Society of Nephrology Annual Meeting

SAN DIEGO and PHILADELPHIA - November 14, 2014 (Investorideas.com newswire) The Aethlon Hemopurifier® was used in the successful treatment of a critically-ill Ebola-infected patient in Frankfurt, Germany, according to data presented today at the American Society of Nephrology (ASN) Annual Meeting by Helmut Geiger, M.D., Chief of Nephrology at Goethe University, Frankfurt University Hospital. Geiger reported that 242 million Ebola viruses were captured within the Aethlon Hemopurifier® during treatment, a number verified by a post-treatment elution protocol. The patient is no longer infected with Ebola virus and is expected to make a full recovery.

Read more: Aethlon Medical ( AEMD )

Breaking Tech News: NXT-ID (NASDAQ: NXTD) to Close Pre-Orders for Wocket(TM) Smart Wallet; First Wockets to Ship in 2014

General Release to Follow 2015 International CES (Consumer Electronics Show)

SHELTON, Conn. - November 10, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (NASDAQ: NXTD), a biometric authentication company focused on the growing mobile commerce market announces it will close pre-orders at midnight on November 14, 2014 in the lead up to its launch of the Wocket™ smart wallet.

Gino Pereira, CEO of NXT-ID, said, "We would like to thank all of our loyal customers for their pre-orders. It was a significant vote of confidence in our product to pay full price in a pre-order phase. We will officially close pre-sale orders of the Wocket Smart Wallet this Friday to prepare for upcoming shipments. Customers who have secured their order will be part of an exclusive group to receive the very first Wockets in the world. We anticipate shipping the first units prior to the end of the year. General release of Wocket to non-pre-order customers will begin following CES in January 2015."

Read more: Breaking Tech News: NXT-ID (NASDAQ: NXTD) to Close Pre-Orders for Wocket(TM) Smart Wallet; First...

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Announces Presentation of Ebola Treatment Data This Friday, November 14th at the ASN Annual Meeting

SAN DIEGO - November 10, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, announced today that treatment data resulting from the administration of Hemopurifier® therapy to a patient infected with Ebola virus will be presented this Friday, November 14th at the American Society of Nephrology (ASN) Annual Meeting.

The treatment data will be presented during an ASN Special Session on Ebola and Dialysis by Professor Helmut Geiger M.D., Chief of Nephrology at Goethe University, Frankfurt University Hospital, where the patient was treated. The data will include the results of patient viral load measurements taken before and after Hemopurifier® administration.

Read more: Aethlon Medical Inc ( AEMD )